Dracen Pharmaceuticals reported raising $2.29 Million in an initial SEC Form D filing, from an offering of $2.79 Million
Round Type
Seed
San DiegoBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as Dracen Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Octave Bioscience raised $30M (Series B) on July 26, 2023.
- RevOpsis Therapeutics raised $7.9M on July 26, 2023.
- Nexo Therapeutics raised $60M (Series A) on July 26, 2023.
- Kriya Therapeutics raised an undisclosed amount (Series C) on July 26, 2023.
- Octave Bioscience raised an undisclosed amount (Funding Round) on July 26, 2023.
- UroGen Pharma raised $120M on July 26, 2023.
Who to call at Dracen Pharmaceuticals, Inc., and when
A new round usually means Dracen Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Dracen Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dracen Pharmaceuticals, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dracen Pharmaceuticals, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dracen Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Dracen Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.